Danaher (DHR) Competitors $205.13 -3.64 (-1.74%) Closing price 10/8/2025 03:59 PM EasternExtended Trading$204.97 -0.16 (-0.08%) As of 04:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DHR vs. RGEN, A, CR, CSL, GFF, IQV, MTD, TMO, WAT, and MMMShould you be buying Danaher stock or one of its competitors? The main competitors of Danaher include Repligen (RGEN), Agilent Technologies (A), Crane (CR), Carlisle Companies (CSL), Griffon (GFF), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), and 3M (MMM). Danaher vs. Its Competitors Repligen Agilent Technologies Crane Carlisle Companies Griffon IQVIA Mettler-Toledo International Thermo Fisher Scientific Waters 3M Danaher (NYSE:DHR) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends. Is DHR or RGEN more profitable? Danaher has a net margin of 14.21% compared to Repligen's net margin of -2.05%. Danaher's return on equity of 10.70% beat Repligen's return on equity.Company Net Margins Return on Equity Return on Assets Danaher14.21% 10.70% 6.85% Repligen -2.05%4.61%3.24% Which has more risk and volatility, DHR or RGEN? Danaher has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Repligen has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Which has stronger earnings and valuation, DHR or RGEN? Danaher has higher revenue and earnings than Repligen. Repligen is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDanaher$23.88B6.15$3.90B$4.7043.64Repligen$673.96M12.59-$25.51M-$0.25-603.24 Does the media refer more to DHR or RGEN? In the previous week, Danaher had 60 more articles in the media than Repligen. MarketBeat recorded 71 mentions for Danaher and 11 mentions for Repligen. Danaher's average media sentiment score of 1.23 beat Repligen's score of 0.59 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 50 Very Positive mention(s) 5 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Repligen 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of DHR or RGEN? 79.1% of Danaher shares are owned by institutional investors. Comparatively, 97.6% of Repligen shares are owned by institutional investors. 11.1% of Danaher shares are owned by company insiders. Comparatively, 1.2% of Repligen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer DHR or RGEN? Danaher currently has a consensus price target of $244.60, suggesting a potential upside of 19.24%. Repligen has a consensus price target of $169.62, suggesting a potential upside of 12.47%. Given Danaher's stronger consensus rating and higher possible upside, equities analysts clearly believe Danaher is more favorable than Repligen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Danaher 0 Sell rating(s) 5 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.77Repligen 1 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.73 SummaryDanaher beats Repligen on 13 of the 17 factors compared between the two stocks. Get Danaher News Delivered to You Automatically Sign up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHR vs. The Competition Export to ExcelMetricDanaherMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$149.49B$8.17B$6.10B$22.02BDividend Yield0.61%2.83%5.69%3.59%P/E Ratio43.6474.0085.6029.86Price / Sales6.1533.35538.2165.92Price / Cash19.1122.8037.9224.43Price / Book2.996.9713.244.64Net Income$3.90B$247.60M$3.30B$1.01B7 Day Performance-2.61%1.11%4.35%0.44%1 Month Performance5.61%0.75%9.51%3.13%1 Year Performance-23.77%13.32%88.04%15.30% Danaher Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHRDanaher4.9826 of 5 stars$205.13-1.7%$244.60+19.2%-23.7%$149.49B$23.88B43.6463,000Trending NewsAnalyst ForecastRGENRepligen4.4538 of 5 stars$124.09-1.2%$168.75+36.0%+11.7%$6.98B$634.44M-496.341,778Analyst ForecastAAgilent Technologies4.001 of 5 stars$123.70+0.3%$140.08+13.2%-2.6%$35.07B$6.51B29.0417,900Trending NewsAnalyst ForecastCRCrane4.6386 of 5 stars$181.41-0.3%$222.20+22.5%+15.0%$10.44B$2.23B24.0311,000Trending NewsAnalyst ForecastCSLCarlisle Companies4.8751 of 5 stars$333.14+1.7%$429.17+28.8%-28.4%$14.24B$5.00B18.615,500Positive NewsAnalyst ForecastGFFGriffon4.8402 of 5 stars$75.53-0.1%$98.20+30.0%+13.0%$3.52B$2.62B56.375,300Analyst DowngradeIQVIQVIA4.8794 of 5 stars$181.00+0.8%$229.64+26.9%-11.5%$30.77B$15.41B26.1988,000Positive NewsAnalyst ForecastMTDMettler-Toledo International3.892 of 5 stars$1,191.70-1.1%$1,325.56+11.2%-8.5%$24.55B$3.87B30.1817,300Analyst ForecastTMOThermo Fisher Scientific4.8911 of 5 stars$461.95-0.5%$588.35+27.4%-9.9%$174.44B$42.88B26.72125,000Trending NewsAnalyst ForecastWATWaters4.5612 of 5 stars$289.19-0.9%$378.73+31.0%-8.6%$17.21B$2.96B26.087,600Trending NewsAnalyst ForecastMMM3M4.221 of 5 stars$154.02+0.8%$161.78+5.0%+15.9%$82.04B$24.58B21.4261,500Positive NewsAnalyst Forecast Related Companies and Tools Related Companies RGEN Alternatives A Alternatives CR Alternatives CSL Alternatives GFF Alternatives IQV Alternatives MTD Alternatives TMO Alternatives WAT Alternatives MMM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DHR) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danaher Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Danaher With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
